$85.00
-0.17 (-0.20%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+157.19%
1Y
+137.10%
YTD
+162.43%
Open$82.29
Previous Close$85.17
Day High$87.54
Day Low$81.55
52W High$88.46
52W Low$23.30
Volume—
Avg Volume2.31M
Market Cap5.45B
P/E Ratio—
EPS$-1.33
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$39.72
Above
SMA 200
$33.17
Above
RSI (14)
70
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
-15.8% upside
Current
$85.00
$85.00
Target
$71.60
$71.60
$49.68
$71.60 avg
$88.34
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 392.08M | 319.41M | 1.46B |
| Net Income | -80,871,751 | -59,294,970 | -327,760,773 |
| Profit Margin | -20.6% | -19.6% | -22.5% |
| EBITDA | -65,135,791 | -50,410,591 | -326,178,396 |
| Free Cash Flow | — | — | -164,017,098 |
| Rev Growth | +22.8% | +22.8% | +7.9% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |